Ignite Creation Date:
2025-12-24 @ 2:32 PM
Ignite Modification Date:
2026-02-11 @ 7:36 AM
Study NCT ID:
NCT03856359
Status:
COMPLETED
Last Update Posted:
2021-12-17
First Post:
2019-01-31
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Trial of Rifaximin in Probable Alzheimer's Disease
Sponsor:
Duke University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-04-09
Start Date Type:
ACTUAL
Primary Completion Date:
2020-11-19
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-11-19
Completion Date Type:
ACTUAL
First Submit Date:
2019-01-31
First Submit QC Date:
None
Study First Post Date:
2019-02-27
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2021-11-18
Results First Submit QC Date:
None
Results First Post Date:
2021-12-17
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-11-18
Last Update Post Date:
2021-12-17
Last Update Post Date Type:
ACTUAL